Method for producing nanoparticles
The lactic acid bacteria bioreactor method produces ultra-nanoparticles that remain stable in an acidic environment, addressing the disintegration issue of metasilicic acid nanoparticles and enabling effective absorption and delivery of fat-soluble components to target tissues.
Patent Information
- Application Number
- JP2023201176
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-11-29
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2043-11-29
AI Technical Summary
Nanoparticles made of metasilicic acid disintegrate in the alkaline environment of the bloodstream, releasing their components, and existing methods produce particles limited to 50 nm to 150 nm, which may not reach target organs or tissues effectively, and are limited to specific fat-soluble components like those in soy milk.
A method using a lactic acid bacteria bioreactor to produce ultra-nanoparticles by encapsulating fat-soluble components with a surfactant and metasilicic acid in an acidic culture solution, forming emulsion structures that break down to create ultra-nanoparticles of 1.0 nm to 10.0 nm.
Ultra-nanoparticles are stable in an acidic environment and can be absorbed by intestinal cells, providing effective pharmaceuticals and functional foods for alleviating allergic symptoms, improving skin conditions, and relieving pain.
Smart Images

Figure 0007589429000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for producing ultra-nanoparticles encapsulating fine fat-soluble components that can be taken up by intestinal cells (M cells) and the like, and to ultra-nanoparticles produced by said method. [Background technology]
[0002] Many plants contain fat-soluble ingredients such as oils. Many animals obtain useful ingredients from plants (vegetables, fruits, nuts, etc.). The digestive enzymes present in the body break down food chewed in the mouth, changing the size of the food into particles that can be absorbed by intestinal cells. The intestinal bacteria that live in the intestines further break down ingredients that cannot be broken down by digestive enzymes, producing nutrients necessary for life activities.
[0003] Meanwhile, throughout history, humans have processed and used a variety of plants in a variety of ways. From boiling and baking to crushing, steaming, and drying, we have devised delicious and efficient ways to absorb the nutrients contained in plants. The method of squeezing the oil contained in soybeans, olives, etc. by applying mechanical pressure has been used for a long time. In this way, ingredients obtained from plants are essential to our lives. In recent years, nutrients contained in plants have been industrially synthesized and commercialized as nutrients and supplements.
[0004] Such nutrients and supplements only become effective once they are absorbed by the body, but many properties are required for useful ingredients taken orally to be incorporated into the body. First, they must not be broken down by stomach acid, second, they must be small enough to be absorbed in the intestinal tract, and third, they must be highly efficient at being absorbed in the intestinal tract. Nutrients and supplements must have properties that satisfy these conditions. Nano-sized (10 -9Nanoparticles (size 1.2-1.5 mm) are small enough to be taken up by living cells. For this reason, many methods have been proposed to process useful ingredients into nano-sized particles, but roughly speaking, two structures have been put to practical use. The first is the micellar structure (emulsion) that uses the principle of soap, and the second structure is the liposome structure formed from phospholipids that mimics living cells.
[0005] The present inventors proposed a method for producing nanoparticles using metasilicic acid in Patent Document 1. Specifically, soy milk is made using hot spring water containing metasilicic acid as preparation water, and lactic acid bacteria (AI-001) are cultured in this soy milk as a culture medium. It was found that the medium becomes acidic due to the lactic acid produced by the lactic acid bacteria, and nanoparticles are obtained in which fat-soluble components (ceramide, equol, etc.) contained in the soy milk are surrounded by the metasilicic acid in the acidic culture medium.
[0006] Patent Document 2 describes a method for producing lactic acid bacteria (AI-001) that control M cells, and Patent Document 3 describes a method for producing filamentous lactic acid bacteria that adsorb IgE antibodies, which are allergy antibodies.
[0007] Patent Document 4 describes a method of binding a drug to a receptor expressed in the blood-brain barrier and transferring it to brain tissue in order to pass through the blood-brain barrier; Patent Document 5 describes an antibody preparation that prevents amyloid beta, the substance that causes Alzheimer's, from increasing in the brain; Patent Document 6 describes cosmetics using liposomes; Patent Document 7 describes a treatment for pulmonary fungal infections using liposomes; and Patent Documents 8 and 9 describe methods for extracting cannabis extract (CBD) as a fat-soluble ingredient.
[0008] Non-Patent Document 1 describes that the brain has central barrier structures known as the blood-brain barrier, blood-spinal cord barrier, blood-cerebrospinal cord barrier, and blood-arachnoid barrier, and that it is often difficult for even nanoparticles to pass through these barriers and reach brain tissue.
[0009] According to Non-Patent Document 2, there is a special immune tissue called Peyer's patch in the intestine, and M cells therein have the ability to take in many components. It has been reported that there are particle sizes that are easily taken up by M cells, but the smaller the particle size, the more it is taken up.
[0010] Non-Patent Documents 3 and 4 describe that many conditions are necessary for nutrients that reach the intestine to be taken up by the body. [Prior art documents] [Patent documents]
[0011] [Patent Document 1] Patent No. 6898620 [Patent Document 2] Patent No. 6190512 [Patent Document 3] Patent No. 5197880 [Patent Document 4] Patent No. 6889218 [Patent Document 5] JP 2023-011002 A [Patent Document 6] Patent No. 2807840 [Patent Document 7] Patent No. 3245955 [Patent Document 8] JP 2023-078465 A [Patent Document 9] Patent Publication No. 2021-042233 [Non-patent literature]
[0012] [Non-Patent Document 1] Hiroyuki Kusuhara, "Molecular structure of the blood-brain barrier and drug transport" Drug Delivery System 27,5, 201 [Non-Patent Document 2] Hideo Hasegawa and Tatsuhiko Suga, "Longevity immunity and lactic acid bacteria: The role of nano-type lactic acid bacteria in inducing Th1 cells," New Food Industry 2008 Vol. 50 No. 8 [Non-Patent Document 3] Yusuke Arai, Toshiya Matsubara, Hyun-ji Kim, Kazuhiko Yamada, "Development of spherical hollow silica nanoparticles," AGC Research Report 71 (2021) [Non-Patent Document 4] Norihiro Nakamura, "Creation and Application of Organic Nanosilica Particles," Microscope Vol. 52, No. 3 (2017) DISCLOSURE OF THEINVENTION [Problem to be solved by the invention]
[0013] Nanoparticles using metasilicic acid remain as fine particles in an acidic environment, but when placed in an alkaline environment, the fine particles break down, releasing the components contained within. Because the blood of the living body is kept weakly alkaline, nanoparticles that enter the blood break down and the components contained within are released into the blood. The metasilicic acid that formed the nanoparticles dissolves in the blood and is used to bind collagen in hair and skin. These nanoparticles have the characteristic that only fat-soluble components are taken up as the nucleus of the nanoparticles. For this reason, these nanoparticles have the ideal properties for allowing functional fat-soluble components to be absorbed by the human body.
[0014] However, the size of the nanoparticles disclosed in Patent Document 1 is limited to 50 nm to 150 nm, and at this size, the functional ingredient may not reach the target organ or tissue. Furthermore, other patent documents and prior art documents do not suggest the production of particles smaller than the above.
[0015] Furthermore, in Patent Document 1, the fat-soluble components that form the core of the nanoparticles are limited to those contained in soy milk, and no verification is made as to whether fine particles can be formed from fat-soluble components that are not contained in soy milk. [Means for solving the problem]
[0016] In order to solve the above problems, the lactic acid bacteria bioreactor of the present invention for producing ultra-nano particles encapsulating fat-soluble components is characterized in that lactic acid bacteria are cultured in a culture solution containing emulsion particles in which the fat-soluble components are encapsulated with a surfactant and metasilicic acid, and the culture solution is gradually made acidic by the lactic acid produced by the lactic acid bacteria, thereby breaking down the emulsion structure and causing the fat-soluble components to leak out from the emulsion particles, and the leaked fat-soluble components are encapsulated in metasilicic acid to form ultra-nano particles.
[0017] Examples of the fat-soluble components include ceramides, equol, polyphenols, aroma oils, cannabidiol (CBD), etc., which are contained in plants such as soybeans, peanuts, grapes, oranges, herbs, and hemp, and examples of surfactants include saponin.
[0018] Moreover, the ultra-nanoparticles encapsulating a fat-soluble component according to the present invention are produced by the above-mentioned method, and are ultra-nanoparticles having a size (particle size) of 1.0 nm to 10.0 nm. Effect of the Invention
[0019] According to the present invention, for example, ultra-nanoparticles encapsulating fat-soluble components of a size that allows them to be easily absorbed by intestinal cells can be produced. Therefore, it is possible to obtain medicines and functional foods that are effective in alleviating allergic symptoms, improving skin conditions, providing healing effects, and reducing pain. [Brief description of the drawings]
[0020] [Figure 1] FIG. 1 is a schematic diagram illustrating the reaction system of the method for producing ultra-nanoparticles according to the present invention. [Diagram 2] A schematic diagram explaining the process from emulsion particles to ultra-nano particles. [Diagram 3] A schematic diagram of the process by which fat-soluble components leak out of emulsion particles. [Figure 4] Photograph showing the relationship between solubility and temperature in sodium metasilicate nonahydrate solutions [Diagram 5] Photograph showing the relationship between the mixture ratio of sodium metasilicate nonahydrate and sodium bicarbonate and their solubility [Figure 6] A photo showing the separation function of fat-soluble components (oil) using sodium metasilicate nonahydrate. [Figure 7] Graph showing the components of the culture obtained by culturing lactic acid bacteria AI-001 [Figure 8] Graph showing particle distribution under different conditions [Figure 9] Graph showing particle distribution under different conditions [Figure 10] Graph showing particle distribution under different conditions [Figure 11] Graph showing particle distribution under different conditions [Figure 12] Graph showing particle distribution under different conditions [Figure 13] Graph showing particle distribution under different conditions [Figure 14] A graph showing the pain relief effect of different cannabidiol (CBD) formulations BEST MODE FOR CARRYING OUT THEINVENTION
[0021] The following is an explanation of the examples of the present invention. As shown in Figure 1, the outline of the present invention is that an emulsion containing fat-soluble components formed by saponin is cultured with lactic acid bacteria in a culture solution in which metasilicic acid is dissolved, and ultra-nano particles encapsulating lipid components are produced in the culture solution.
[0022] Metasilicic acid (H2SiO3) is silicon dioxide plus water, and in this example, commercially available sodium metasilicate nonahydrate (herein referred to as SiO2) was used. Sodium bicarbonate was added to dissolve more sodium metasilicate nonahydrate in water.
[0023] Figure 4 shows a comparison of solubility as a function of temperature, and while at room temperature the solution is cloudy and has low solubility, when boiling sodium metasilicate nonahydrate (SiO2) and sodium bicarbonate (Na2HCO3) is used, no cloudiness is observed and the solubility is high. Therefore, when dissolving sodium metasilicate nonahydrate and sodium bicarbonate, it is preferable to boil the solution.
[0024] Figure 5 shows the results of a test conducted on the mixing ratio of sodium metasilicate nonahydrate and sodium hydrogen carbonate. A ratio of 2:1 for sodium metasilicate nonahydrate:sodium hydrogen carbonate produced the least amount of precipitation, and this ratio is preferable.
[0025] Figure 6 shows the separation effect of fat-soluble components (oil). 2g of sodium metasilicate nonahydrate and 1g of sodium bicarbonate were added to 1 liter of boiled water, and 30g of orange peel powder (Natt Herbman, ETSY, USA) was added to this boiled solution and boiled for another 30 minutes. The left photograph in Figure 6 shows the state 0 hours after boiling, and the right photograph shows the state after 24 hours of keeping at 40℃. Floating matter can be seen in the photo on the right, and it can be inferred that metasilicic acid is highly effective at breaking down orange peel and separating fat-soluble components (oil).
[0026] Instead of the water, soy milk containing nutrients that enable the growth of lactic acid bacteria was used, and sodium metasilicate nonahydrate, sodium bicarbonate, and orange peel were added to this soy milk, boiled, and then maintained at 40°C. Lactic acid bacteria (AI-001) were then added to the 40°C solution (culture solution) and cultured for six days.
[0027] The above treated culture was dried and subjected to a series of cannabidiol (CBD) analyses by high performance liquid chromatography (HPLC) (left table in Figure 7). On the other hand, only orange peel was analyzed in the same manner (right table in Figure 7). As a result, it can be seen that a small amount of CBD was detected in the treated culture in which lactic acid bacteria AI-001 was cultivated.
[0028] Incidentally, CBD is a functional fat-soluble ingredient that has been approved in many countries for use in suppressing excessive neurotransmission, relieving pain, and improving sleep, and is currently being discussed in the Diet in Japan so that it can be used clinically as an anti-epileptic drug. In addition, undetectable THC is treated as a narcotic ingredient.
[0029] Next, the plant-derived surfactant saponin, cannabidiol (CBD), sodium bicarbonate (Na2HCO3), and sodium metasilicate nonahydrate (SiO2) were added sequentially to a medium (soy milk) in which lactic acid bacteria could grow, and the particle size and number of particles formed at each step were measured using a zeta potential, particle size, and molecular weight measurement system ELSZ-2000 series (Otsuka Electronics, Kyoto).
[0030] FIG. 8 shows the change in the particle distribution described above, with the horizontal axis representing particle size, the left vertical axis representing number distribution %, and the right vertical axis representing cumulative frequency distribution %. When fat-soluble CBD was added to a solution containing saponin (1) (2), it dissolved due to the surfactant properties of saponin. Furthermore, Na2HCO3 and SiO2 were mixed into this solution in the same ratio as above, and the particles were measured (3)(4). As a result, nanoparticles with a particle size of about 160 nm were formed in (1) and (2), and about 80 nm in (3)(4).
[0031] In the above test, solutions were prepared with and without the addition of fat-soluble CBD, and the particle size and number distribution % were measured in the same manner as above. As a result, as shown in Figure 9, when fat-soluble CBD was added, the number of fine particles of about 200 nm seen in [(5)-CBD] decreased, and fine particles mainly with a size of about 80 nm were formed (5). It was speculated that the presence of fat-soluble CBD formed an emulsion surrounded by the plant surfactant saponin.
[0032] In this way, the presence or absence of the fat-soluble component CBD can change the particle distribution. When CBD is not added, the particles circled in [(5)- CBD] in Figure 9 match the particle size in Figure 8(1) when only saponin is added. When CBD is added, the number of particles in this range decreases, and instead there is an increase in particles of a size thought to be an emulsion containing the fat-soluble component CBD.
[0033] Lactic acid bacteria AI-001 was added to the solution in Figure 9(5) and aerobically cultured for 6 days at 40°C. As a result, even smaller nanoparticles (average 1.9 nm) were observed, as shown in Figure 10(6).
[0034] On the other hand, in the case of the sample without CBD (Figure 10 [(6)- CBD]), only fine particles with an average size of 51 nm were observed. It was speculated that the emulsion of saponin with CBD as the core caused the lactic acid bacteria AI-001 to form even smaller nanoparticles (ultra-nanoparticles).
[0035] When lactic acid bacteria (AI-001) are cultured together, the culture medium gradually becomes acidic, and it is observed that the particles of the emulsion (4) change into even smaller particles (6). Furthermore, if CBD is not added, no further small particles are formed. This is presumably because even if saponin is broken down, it does not contain any fat-soluble components, and therefore the ultra-nano particles made of metasilicic acid are not produced.
[0036] We observed whether ultra-nano particles were formed in the presence or absence of SiO2. The results are shown in Figure 11. Lactic acid bacteria AI-001 was added to a solution without added SiO2, and cultured at 40°C for six days. As a result, no ultra-nano particles were formed (7). The results were almost the same as when lactic acid bacteria AI-001 was added to a solution containing only soy milk, with nothing added, and cultured at 40°C for six days (negative control) (8). This shows that ultra-nano particles are not formed unless SiO2 is added, which means that ultra-nano particles are made of SiO2 (that is, made of dissolved metasilicic acid).
[0037] The culture solution in which the ultra-nano particles were formed had a pH of 4.1. This solution was adjusted to pH 9.0 with a sodium hydroxide solution. The results of measuring this solution with a particle sizer are shown in Figure 12(9). As a result of making the solution alkaline, the ultra-nano particles disappeared, and instead, particles with a bimodal distribution with peaks at 70 nm and 700 nm were detected. Next, hydrochloric acid solution was added to this solution to adjust the pH to 3.0 (10). As a result, ultra-nano particles with an average size of 1.5 nm were detected.
[0038] That is, ultra-nano particles are stable in an acidic solution, but in an alkaline solution, the ultra-nano particles dissolve and may aggregate to form large aggregates.
[0039] CBD was added to the solution containing saponin so that the concentration was 10 g / L. To form an emulsion of the dissolved saponin, the solution was homogenized (Marusan Machinery, Shizuoka), and Na2HCO3 and SiO2 were added in that order, and lactic acid bacteria AI-001 was cultivated. As a result, ultra-nano particles with an average size of 1.0 nm were detected (Figure 13(11)).
[0040] FIG. 14 is a graph verifying the effect of making the particles into ultra-nano particles. A liquid containing Saponin, CBD, Na2HCO3, and SiO2 was made from soy milk, and then lactic acid bacteria AI-001 was inoculated and cultivated to create soy milk yogurt. Subject A was asked to consume 100 ml of the liquid every day. Subject A has persistent lower back pain due to severe sciatic nerve pain. Subject A was asked to evaluate the pain relief caused by consuming soy milk yogurt by dividing it into five scores (4: no pain, 3.5: occasional pain, 3: pain when pressed, 2.5: pain awareness, 2: pain all the time). Soy milk yogurt with various combinations of Saponin, CBD, Na2HCO3, and SiO2 was consumed and evaluated. One pattern of consumption was continued for 7 days, the highest and lowest scores were deleted, and the average score for the remaining 5 days was used as the evaluation value. As a result, the solution in which Saponin, CBD, Na2HCO3, and SiO2 were dissolved in sequence was found to have excellent lower back pain relief effects.
[0041] A clinical evaluation was conducted to confirm the tissue migration of the fat-soluble components contained in the ultra-nano particles, and it was confirmed that the fat-soluble components could be transported to the nerves. There are various possible causes of sciatica, but it is thought that the function of CBD in suppressing excessive neurotransmission at the nerve synapse reduces pain. Ultra-nano particles containing fat-soluble components can contribute to the efficiency of intestinal absorption and the effect of tissue migration.
[0042] In summary, by sequentially adding the plant-based surfactant saponin and CBD to a medium (soy milk) in which lactic acid bacteria can grow, emulsion particles incorporating CBD are formed, as shown in Figure 2. The same experiment was carried out using aromatic oils other than CBD as fat-soluble components, and ultra-nano particles were detected. In order to produce ultra-nano particles, it is necessary to add Saponin, fat-soluble components, Na2HCO3, and SiO2, and then culture the lactic acid bacteria in the above order.
[0043] Furthermore, since the above solution is a culture medium containing nutrients such as soy milk that allow lactic acid bacteria to grow, the culture medium becomes acidic due to the lactic acid produced by the lactic acid bacteria. As the lactic acid bacteria grow, the surfactant is decomposed into hydrophilic and lipophilic parts as shown in Figure 3, and the emulsion particles disintegrate, causing the fat-soluble components to leak out from the emulsion particles. The leaked fat-soluble components are surrounded by metasilicic acid, as the culture medium has become an acidic metasilicic acid solution due to the lactic acid from the lactic acid bacteria, and become ultra-nano particles (micelle structures) of 1.0 to 10.0 nm.
[0044] Here, soy milk is merely a solution that provides nutrients for the growth of lactic acid bacteria, so any solution other than soy milk in which lactic acid bacteria can grow may be used. In addition, lactic acid bacteria function as a bioreactor that can carry out a series of reactions in the same container, such as gradually acidifying the environment with lactic acid in a small reaction space, breaking down the emulsion with saponin at an optimal pH, and forming ultrafine particles with the leaked fat-soluble components and metasilicic acid, so the type of lactic acid bacteria is not limited to AI-001, but since the reaction space is formed by the bacterial cell size of the lactic acid bacteria increasing with growth, lactic acid bacteria that are larger than other lactic acid bacteria, such as AI-001, are preferred.
[0045] Furthermore, sodium bicarbonate makes sodium metasilicate nonahydrate easier to dissolve. It also has the effect of reducing the particle size of emulsions containing fat-soluble ingredients [Figure 8 (3)]. Sodium bicarbonate is not necessarily required, but sodium bicarbonate is preferable.
Claims
1. A method for producing nanoparticles, comprising culturing lactic acid bacteria in a culture solution containing emulsion particles in which fat-soluble components are encapsulated with a surfactant and metasilicic acid, causing the fat-soluble components to leak from the emulsion particles as the lactic acid bacteria grow, and encapsulating the leaked fat-soluble components with metasilicic acid in the acidified culture solution to form nanoparticles having a particle size of 1.0 nm to 10 nm.
2. 2. The method for producing nanoparticles encapsulating a fat-soluble component according to claim 1, wherein the fat-soluble component is a fat-soluble component contained in a plant or a fat-soluble component added to a solution, and the surfactant is saponin.
Citation Information
Patent Citations
Small-particle size nanometer polysilicon emulsion and preparation method thereof
CN104830300A
********na*shi
JP1976097880A
Mounting device of disc shaped work
JP1986090512A
Bio-applicable nano-particles
JP2019170183A
Cannabis extracts and preparation and use methods thereof
JP2021042233A
